According to Zacks, “Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient and physician alignment solutions. The company focuses on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings, Inc. is headquartered in Glendale, CA. “
Separately, ValuEngine upgraded shares of Apollo Medical from a hold rating to a buy rating in a research note on Tuesday, December 24th.
NASDAQ AMEH opened at $18.25 on Monday. Apollo Medical has a 12 month low of $13.02 and a 12 month high of $23.26. The company has a debt-to-equity ratio of 1.28, a current ratio of 3.05 and a quick ratio of 3.05. The company has a market capitalization of $625.27 million, a price-to-earnings ratio of 62.93, a price-to-earnings-growth ratio of 2.82 and a beta of -0.86. The company’s fifty day moving average price is $18.25 and its two-hundred day moving average price is $16.97.
Apollo Medical (NASDAQ:AMEH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.14 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.14. Apollo Medical had a net margin of 0.88% and a return on equity of 3.16%. The firm had revenue of $156.06 million for the quarter. As a group, analysts anticipate that Apollo Medical will post 0.4 EPS for the current year.
In other Apollo Medical news, CEO Thomas S. Lam purchased 10,000 shares of Apollo Medical stock in a transaction dated Thursday, November 14th. The shares were bought at an average cost of $16.30 per share, for a total transaction of $163,000.00. Also, major shareholder Physicians Of Californi Allied purchased 12,599 shares of Apollo Medical stock in a transaction dated Tuesday, January 14th. The stock was acquired at an average price of $17.92 per share, for a total transaction of $225,774.08. Over the last 90 days, insiders bought 303,058 shares of company stock worth $5,428,152. Insiders own 11.83% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. Rhumbline Advisers bought a new position in shares of Apollo Medical in the 3rd quarter worth about $526,000. State Street Corp lifted its position in shares of Apollo Medical by 189.8% in the 3rd quarter. State Street Corp now owns 498,197 shares of the company’s stock worth $8,778,000 after buying an additional 326,304 shares during the last quarter. Barclays PLC lifted its position in shares of Apollo Medical by 238.7% in the 3rd quarter. Barclays PLC now owns 13,790 shares of the company’s stock worth $243,000 after buying an additional 9,719 shares during the last quarter. California State Teachers Retirement System increased its holdings in shares of Apollo Medical by 338.8% in the 3rd quarter. California State Teachers Retirement System now owns 42,628 shares of the company’s stock worth $751,000 after acquiring an additional 32,913 shares during the period. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Apollo Medical in the 3rd quarter worth about $387,000. Institutional investors own 15.96% of the company’s stock.
About Apollo Medical
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Featured Story: New Google Finance Tool and Screening Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.